Clinical Trial Update: Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of carfilzomib and sotorasib for KRAS G12C-mutated advanced or metastatic non-small cell lung cancer, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Kyprolis (carfilzomib)
• LUMAKRAS (sotorasib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Phase 1 | Status: RECRUITING